(Q38140700)

English

Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24057419%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24057419%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

Daniele Pastori

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24057419%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Roberto Carnevale

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24057419%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Pasquale Pignatelli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24057419%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Daniele Pastori

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Roberto Carnevale

2

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Pasquale Pignatelli

3

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

publication date

22 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24057419%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Internal and emergency medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24057419%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24057419%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24057419%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

123-131

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24057419%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

https://scigraph.springernature.com/pub.10.1007/s11739-013-0999-6

0 references

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Role of oxidative modifications in atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Advanced glycation end-products: a review

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Oxidative stress in vascular disease and its pharmacological prevention.

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Role of NADPH oxidase in atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Human obesity and endothelium-dependent responsiveness

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

The neutrophil NADPH oxidase

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers.

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition.

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

gp91phox-dependent expression of platelet CD40 ligand

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Platelet isoprostane overproduction in diabetic patients treated with aspirin

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

F2-isoprostanes as an indicator and risk factor for coronary heart disease

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Platelet activation in obese women: role of inflammation and oxidant stress

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Serum myeloperoxidase levels independently predict endothelial dysfunction in humans.

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Association between myeloperoxidase levels and risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Prognostic value of myeloperoxidase in patients with chest pain

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis.

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Oxidized LDL and the Risk of Coronary Heart Disease: Results from the MONICA/KORA Augsburg Study

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Myeloperoxidase Predicts Progression of Carotid Stenosis in States of Low High-Density Lipoprotein Cholesterol

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Obesity and Hypercholesterolemia are Associated with NOX2 Generated Oxidative Stress and Arterial Dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Nox2 Is Determinant for Ischemia-Induced Oxidative Stress and Arterial Vasodilatation: A Pilot Study in Patients With Hereditary Nox2 Deficiency

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Does NADPH Oxidase Deficiency Cause Artery Dilatation in Humans?

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Anoxia-Reoxygenation Enhances Platelet Thromboxane A 2 Production via Reactive Oxygen Species–Generated NOX2

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Reduced Atherosclerotic Burden in Subjects With Genetically Determined Low Oxidative Stress

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Inherited Human gp91 phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet Dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Radiolabeled Native Low-Density Lipoprotein Injected Into Patients With Carotid Stenosis Accumulates in Macrophages of Atherosclerotic Plaque

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease

1 reference

https://api.crossref.org/works/10.1007%2FS11739-013-0999-6

21 January 2018

Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of platelets in NOX2 activation mediated by TNFα in heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical and ELISA assays for biomarkers of oxidative stress in aging and disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic granulomatous disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NOX2 up-regulation is associated with artery dysfunction in patients with peripheral artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina

1 reference

https://pubmed.ncbi.nlm.nih.gov/24057419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38140700&oldid=1510794638"